Serotonergic Therapies for Cognitive Symptoms in Alzheimer’s Disease: Rationale and Current Status-Reference-Cited by-同舟云学术

Serotonergic Therapies for Cognitive Symptoms in Alzheimer’s Disease: Rationale and Current Status

Published:2014-05 Issue:7 Volume:74 Page:729-736
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Ramirez Maria J.,Lai Mitchell K. P.,Tordera Rosa M.,Francis Paul T.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-014-0217-5.pdf

Reference80 articles.

1. Alzheimer’s Association. http://www.alz.org . Accessed 17 Apr 2014.

2. Alzheimer´s Association. Alzheimer’s Association TrialMatch®. http://www.alz.org/research/clinical_trials/find_clinical_trials_trialmatch.asp . Accessed 17 Apr 2014.

3. Geldenhuys WJ, Van der Schyf CJ. Role of serotonin in Alzheimer’s disease: a new therapeutic target? CNS Drugs. 2011;25(9):765–81.

4. Codony X, Vela JM, Ramírez MJ. 5-HT(6) receptor and cognition. Curr Opin Pharmacol. 2011;11:94–100.

5. Ramírez MJ. 5-HT6 receptors and Alzheimer’s disease. Alzheimers Res Ther. 2013;5(2):15.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the most promising anti ‐ Depressant drug targeting Microtubule Affinity Receptor Kinase 4 involved in Alzheimer’s Disease through molecular docking and molecular dynamics simulation;PLOS ONE;2024-07-25

2. Dorsal raphe nucleus–hippocampus serotonergic circuit underlies the depressive and cognitive impairments in 5×FAD male mice;Translational Neurodegeneration;2024-07-24

3. Electroacupuncture Alleviates Memory Deficits in APP/PS1 Mice by Targeting Serotonergic Neurons in Dorsal Raphe Nucleus;Current Medical Science;2024-07-11

4. Amygdala neuronal dyshomeostasis via 5‐HT receptors mediates mood and cognitive defects in Alzheimer's disease;Aging Cell;2024-05-08

5. Network pharmacology-based analysis of Jin-Si-Wei on the treatment of Alzheimer's disease;Journal of Ethnopharmacology;2024-01